Kezar Life Sciences (NASDAQ:KZR) just reported results for the fourth quarter of 2023.
- Kezar Life Sciences reported earnings per share of -44 cents. This was below the analyst estimate for EPS of -38 cents.
- The company did not report any revenue for the quarter.